Moreover, MDSCs secrete copious amounts of TGF-β, and this cytokine level is elevated in myeloid neoplasm [235,236]; it is plausible that TGF-β1 inhibition may also considerably reduce the number of MDSCs and simultaneously restore the MSC function in the BM niche. Here, TGFB1 is linked to myeloid neoplasm.